Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Egle Therapeutics is a spin-out of Institut Curie in France, developing immunotherapies targeting suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The key element of Egle’s core approach is the leveraging of its translational-based target discovery engine to unveil novel therapeutic Treg targets and vectorize computationally designed resurfaced cytokines acting as antagonists or […]
Founded in 2020, US-based Known Medicine is aiming to help oncologists select the best treatment for cancer patients by providing new insights into how patients’ cells will respond to different treatments. The company is an extension of Co-Founder Andrea Mazzocchi’s research at Wake Forest University, where she recently completed a Ph.D. in biomedical engineering. The […]
France-based Qubit Pharmaceuticals was founded in 2020 with the vision of becoming a world leader in quantum-assisted drug development. Its software makes the most of existing and emerging supercomputers to model quantum effects at the microscopic level with high precision. The company aims to work alongside pharmaceutical and biotechnology companies to reduce the cost and […]